VIAVVIAVI SOLUTIONS INC.

Nasdaq viavisolutions.com


$ 8.02 $ 0.04 (0.5 %)    

Friday, 26-Apr-2024 15:59:30 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 8.01
$ 7.98
$ 0.00 x 0
$ 0.00 x 0
$ 7.98 - $ 8.15
$ 7.26 - $ 11.65
835,864
na
1.79B
$ 1.15
$ 358.05
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-02-2024 12-30-2023 10-Q
2 11-03-2023 09-30-2023 10-Q
3 08-17-2023 07-01-2023 10-K
4 05-03-2023 04-01-2023 10-Q
5 02-03-2023 12-31-2022 10-Q
6 11-04-2022 10-01-2022 10-Q
7 08-19-2022 07-02-2022 10-K
8 05-05-2022 04-02-2022 10-Q
9 02-07-2022 01-01-2022 10-Q
10 11-08-2021 10-02-2021 10-Q
11 08-23-2021 07-03-2021 10-K
12 05-07-2021 04-03-2021 10-Q
13 02-09-2021 01-02-2021 10-Q
14 11-10-2020 10-03-2020 10-Q
15 08-24-2020 06-27-2020 10-K
16 05-07-2020 03-28-2020 10-Q
17 02-06-2020 12-28-2019 10-Q
18 11-05-2019 09-28-2019 10-Q
19 08-27-2019 06-29-2019 10-K
20 05-08-2019 03-30-2019 10-Q
21 02-06-2019 12-29-2018 10-Q
22 11-07-2018 09-29-2018 10-Q
23 08-28-2018 06-30-2018 10-K
24 05-09-2018 03-31-2018 10-Q
25 02-07-2018 12-30-2017 10-Q
26 11-08-2017 09-30-2017 10-Q
27 08-29-2017 07-01-2017 10-K
28 05-09-2017 04-01-2017 10-Q
29 02-07-2017 12-31-2016 10-Q
30 11-08-2016 10-01-2016 10-Q
31 08-30-2016 07-02-2016 10-K
32 05-10-2016 04-02-2016 10-Q
33 02-09-2016 01-02-2016 10-Q
34 11-12-2015 10-03-2015 10-Q
35 08-25-2015 06-27-2015 10-K
36 05-05-2015 03-28-2015 10-Q
37 02-05-2015 12-27-2014 10-Q
38 11-04-2014 09-27-2014 10-Q
39 08-26-2014 06-28-2014 10-K
40 05-07-2014 03-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rosenblatt-maintains-buy-on-viavi-solutions-lowers-price-target-to-13

Rosenblatt analyst Mike Genovese maintains Viavi Solutions (NASDAQ:VIAV) with a Buy and lowers the price target from $15 to ...

 stifel-maintains-buy-on-viavi-solutions-maintains-13-price-target

Stifel analyst Ruben Roy maintains Viavi Solutions (NASDAQ:VIAV) with a Buy and maintains $13 price target.

 needham-reiterates-hold-on-viavi-solutions

Needham analyst Alex Henderson reiterates Viavi Solutions (NASDAQ:VIAV) with a Hold.

 susquehanna-maintains-positive-on-viavi-solutions-raises-price-target-to-14

Susquehanna analyst Mehdi Hosseini maintains Viavi Solutions (NASDAQ:VIAV) with a Positive and raises the price target from ...

 morgan-stanley-maintains-equal-weight-on-viavi-solutions-raises-price-target-to-11

Morgan Stanley analyst Meta Marshall maintains Viavi Solutions (NASDAQ:VIAV) with a Equal-Weight and raises the price target...

 rosenblatt-maintains-buy-on-viavi-solutions-raises-price-target-to-15

Rosenblatt analyst Mike Genovese maintains Viavi Solutions (NASDAQ:VIAV) with a Buy and raises the price target from $13 to ...

 viavi-accelerates-innovation-with-spirent-acquisition-targeting-75m-in-synergies

VIAVI Solutions to acquire Spirent Communications for $1.3 billion in cash, creating a provider of test and assurance solutions...

 viavi-solutions-agrees-to-acquire-spirent-communications-valued-at-13b

VIAVI Solutions ("VIAVI") (NASDAQ:VIAV), a leading provider of communications test, measurement and optical technologie...

 viavi-xgig-exerciser-approved-for-cxl-11-gold-suite-compliance-testing

VIAVI Solutions Inc. (VIAVI) (NASDAQ:VIAV) today announced that the VIAVI Xgig® CXL Exerciser has been recognized as a CXL 1.1 ...

 why-big-lots-shares-are-trading-lower-by-around-31-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarte...

 cymabay-therapeutics-contextlogic-snap-and-other-big-stocks-moving-higher-on-monday

U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION